Your browser doesn't support javascript.
loading
A primary thymic adenocarcinoma with two components that traced distinct evolutionary trajectories.
Ishida, Ayami; Yamada, Yosuke; Ishida, Yoshihiro; Yoshizawa, Akihiko; Nakajima, Daisuke; Date, Hiroshi; Marx, Alexander; Haga, Hironori.
Afiliação
  • Ishida A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Yamada Y; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Ishida Y; Department of Dermatology, Kyoto University Hospital, Kyoto, Japan.
  • Yoshizawa A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Nakajima D; Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.
  • Date H; Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.
  • Marx A; Institute of Pathology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Haga H; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
Pathol Int ; 71(12): 849-855, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34583424
Even though it is a rare subtype, identifying the genetic features of thymic adenocarcinoma is valuable for a multifaceted understanding of thymic epithelial tumors. We experienced a female patient with thymic adenocarcinoma associated with thymic cysts. The tumor consisted of a solid whitish lesion (lesion-1) and a large cystic lesion with small papillary nodules (lesion-2). Microscopically, lesion-1 exhibited poorly differentiated adenocarcinoma accompanying numerous inflammatory cell infiltrates, and lesion-2 (the nodules within the cystic lesion) exhibited enteric-type adenocarcinoma. Consistent with the histological difference, whole-exome sequencing revealed that these two components exhibited distinct genetic features, except for only a few shared mutations, including CDKN2A truncation. Lesion-1 exhibited microsatellite instability-high signature with high mutation burden, for which immune checkpoint inhibitors might apply; and lesion-2 exhibited whole-genome doubling with KRAS hotspot mutation. Our case presents novel genetic features of thymic adenocarcinoma and demonstrates that distinct mutational processes can be operative within a single tumor.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Adenocarcinoma / Proteínas Proto-Oncogênicas p21(ras) / Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Timo / Adenocarcinoma / Proteínas Proto-Oncogênicas p21(ras) / Inibidor p16 de Quinase Dependente de Ciclina Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article